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A novel locus for autosomal dominant cone-rod
dystrophy maps to chromosome 10q
Kunka Kamenarova1, Sylvia Cherninkova2, Margarita Romero Dura´n1, DeQuincy Prescott3,
Maria Lourdes Valde´s Sa´nchez1, Vanio Mitev4,5, Ivo Kremensky4,6, Radka Kaneva4,5, Shomi S Bhattacharya1,3,
Ivailo Tournev2 and Christina Chakarova*,3
Here we report recruitment of a three-generation Romani (Gypsy) family with autosomal dominant cone-rod dystrophy (adCORD).
Involvement of known adCORD genes was excluded by microsatellite (STR) genotyping and linkage analysis. Subsequently,
two independent total-genome scans using STR markers and single-nucleotide polymorphisms (SNPs) were performed. Haplotype
analysis revealed a single 6.7-Mb novel locus between markers D10S1757 and D10S1782 linked to the disease phenotype
on chromosome 10q26. Linkage analysis gave a maximum LOD score of 3.31 for five fully informative STR markers within
the linked interval corresponding to the expected maximum in the family. Multipoint linkage analysis of SNP genotypes yielded
a maximum parametric linkage score of 2.71 with markers located in the same chromosomal interval. There is no previously
mapped CORD locus in this interval, and therefore the data reported here is novel and likely to identify a new gene that may
eventually contribute to new knowledge on the pathogenesis of this condition. Sequencing of several candidate genes within
the mapped interval led to negative findings in terms of the underlying molecular pathogenesis of the disease in the family.
Analysis by comparative genomic hybridization excluded large chromosomal aberrations as causative of adCORD in the pedigree.
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INTRODUCTION
Cone-rod dystrophies (CORDs) are a group of clinically and
genetically heterogeneous retinal disorders with prevalence of
1/40 000 and characterized by primary degeneration of cone photo-
receptors, followed by loss of rod photoreceptors. Affected individuals
initially show symptoms of decreased visual acuity and abnormalities
of color vision, visual field loss and a variable degree of nystagmus
and photophobia. Central or paracentral scotomas can also be present
upon visual testing. The fundus examination often reveals pigment
deposits and retinal atrophy in the macular region. Patients with
CORD develop additional rod system abnormalities that lead to night
blindness later in the disease process.1
Autosomal dominant, autosomal recessive and X-linked (Xl)
inheritance patterns are seen in CORD families.2 Currently, ten
genes, including AIPL1 (17p13.2), CRX (19q13.32), GUCA1A
(6p21.1), GUCY2D (17p13.1), PITPNM3 (17p13.2), PROM1
(4p15.32), PRPH2 (6p21.2), RIMS1 (6q13), SEMA4A (1q22) and
UNC119 (17q11.2) and three loci, CORD4 (17q), RCD1 (6q25-q26)
and CORD16 (2q24.2-2q33.1) have been identified as responsible for
autosomal dominant cone-rod dystrophy (adCORD) (http://
sph.uth.tmc.edu/Retnet). The products of these genes are associated
either with photoreceptor structure, cellular function including the
phototransduction cascade, or synaptic transmission.
Here, we describe a three-generation Bulgarian family of Romani
origin segregating adCORD (Figure 1) and provide evidence for a
novel, still unidentified locus implicated in this condition. Romani are
known as a genetically isolated founder population of Indian origin
that settled in the Balkans in 13th–14th century and rest of Europe by
the end of the 15th century.3,4 A large group of the initial migrant
population, called ‘Balkan Gypsies,’ settled permanently in the
Balkans, south of the Danube in Bulgaria. Interestingly the various
geographically, socially and linguistically divergent Romani groups
have been shown to share common Mendelian disorders and founder
mutations due to their common origin.3
MATERIALS AND METHODS
Phenotyping
A three-generation autosomal dominant family of Romani origin with non-
syndromic CORD was identified. A total of 6 affected and 15 unaffected
individuals were clinically ascertained. Diagnosis of CORD was based on the
following criteria: reduced visual acuity and photophobia evident in the second
decade of life, impairment of color vision, fundoscopic evidence of maculo-
pathy with peripheral retinopathy and the demonstration of an abnormal
cone-rod ERG.
Genotyping, linkage analysis and mutation screening
After informed consent, blood samples were obtained and genomic DNA
extracted from peripheral blood lymphocytes according to the standard
protocols. In total, 460 fluorescently labeled microsatellite (STRs) markers
from the ABI PRISM Linkage Mapping Set V2.5 (Applied Biosystems
Incorporated, Foster City, CA, USA) were used for genotyping of 21 members
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of this family. Multiplex microsatellite genotyping was performed using 3–5
markers per reaction using QPCR mix (ABgene, Epsom, Surrey, UK) and
subsequently analyzed on an ABI3730xl genetic analyzer (Applied Biosystems).
Data collection and allele identification were performed using GeneScan and
GeneMapper v4.0 software (Applied Biosystems). All regions with suggestive
LOD scores (41.5) were saturated with additional highly polymorphic
markers designed according to the information obtained from Marshfield,
GDB Human Genome Database (http://research.marshfieldclinic.org) and
Ensembl genome data resources (http://www.ensembl.org).
Two- and multipoint parametric linkage analysis was performed with
FastLink and Genehunter, respectively, from easyLINKAGE-Plus package.5
PedCheck was used for detection of Mendelian errors,6 and non-Mendelian
errors were identified with Merlin.7 The phenotype was analyzed as an
autosomal dominant trait with complete penetrance (0.9990) and a
frequency of 0.0001 for the affected allele. Because of the computational
limitations of Genehunter and the size of the family, the pedigree was split into
two halves for LOD score analysis.
To confirm the STR linkage, a second genome-wide scan was performed
using DNA samples from 15 family members genotyped on the Affymetrix 10K
SNP panel (AROS Applied Biotechnologies, Aarhus, Denmark). This version
of microarray (v.Xba142 2.0) comprises a total of 10 204 single-nucleotide
polymorphisms (SNPs) with a mean intermarker distance of 258 kb, equivalent
to 0.36 cM and average heterozygosity of 0.38 predicting a spacing of three
fully informative markers per 1Mb. Genome-wide linkage analysis via the
Genehunter program in the easyLINKAGE plus platform v5.088 was used to
validate the original STR linkage. The call rate, defined as the percentage of
successful genotype calls among subjects, was used as a measure of data quality.
The results reported in this study are based on 95% call rate. Uninformative
SNPs were removed from the data by Merlin.7
Sequence analysis of the coding exons, intron–exon junctions and 50 and 30
untranslated regions of all genes within the linkage region, was performed on
ABI3730xl genetic analyzer (Applied Biosystems) according to the manufac-
turer’s protocol. All novel sequence variants were tested using control
individuals from Human Random Control DNA Panels (European Collection
of Cell Cultures).
Whole-genome and chromosome 10 tiling comparative genomic hybridiza-
tion (CGH) arrays (Roche NimbleGen, Incorporated, Madison, WI, USA)
were undertaken using the 385K version. Fluorescence intensities and log2
intensity ratios for the test versus control sample were calculated using the
SignalMap software (Roche NimbleGen).
Figure 1 Pedigree of the family is shown with haplotypes of STR markers spanning the linked interval on chromosome 10. Markers and their physical
positions (Mb) are indicated at the left of each row. Open symbols represent unaffected and filled symbols represent affected individuals; symbols with
diagonal slash represent deceased members; arrow indicates the proband; black vertical bars represent haplotype segregating with the disease in the family.
Twenty-one members indicated with asterisks were genotyped. Predicted haplotypes for individuals I:1 and I:2 are enclosed in brackets. Haplotypes were
created with Genehunter and viewed on Haplopainter.15
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RESULTS
We first excluded all previously known loci for adCORD using
selected microsatellite markers closely linked to these loci. Non-
segregation of the marker haplotypes within the family for a given
adCORD locus ruled out its involvement in the pathogenesis of the
disease. Total-genome scan using highly informative STRs was then
performed and the generated negative or non-significant LOD scores
for all genotyped loci allowed exclusion of all regions, except for eight
different intervals on chromosome 1 (one interval of 74Mb between
D1S435 and D1S2878), chromosome 5 (one interval of 49Mb
between D5S471 and D5S400), chromosome 10 (one interval of
40Mb between D10S1765 and D10S217), chromosome 14 (three
intervals of 10, 13 and 38Mb between D14S972 and D14S70,
D14S288 and D14S980 and D14S274 and D14S1054, respectively),
chromosome 17 (one interval of 5.8Mb between D17S785 and
D17S928) and chromosome 20 (one interval of 9.6Mb between
D20S115 and D20S112). Consequently, additional densely spaced
microsatellite markers spanning these regions were used and haplo-
types were constructed. The segregation of different haplotypes in
affected individuals and the negative LOD scores obtained allowed
exclusion of all regions except a 6.7-Mb interval on chromosome
10q26, which could not be further refined. Recombination in
unaffected individual II:3 at D10S1757 (122 324 738 bp) defined the
proximal boundary and similarly, recombination event in affected
individual II:1 at D10S1782 (129 086 934 bp) defined the distal
boundary of the region (Figure 1). Thus, the linked interval on
chromosome 10q26 (122 324 738–129 086 934 bp) was reduced from
40 to 6.7Mb, and therefore the number of the genes needed to
be screened for mutation was greatly decreased from approximately
200 to only 46. Affected individuals shared a common haplotype
tested with a number of microsatellite markers spanning the linked
region and generating positive LOD score. Five fully informative
markers, D10S1757 (122 324 738 bp), D10S1230 (122 742 692 bp),
D10S1679 (123133 534bp), D10S587 (125188 640bp) and D10S1213
(125 406 637 bp), within this interval yielded maximum LOD score
of 3.31 at y¼ 0.0 (Table 1).
A second genome scan using the 10K SNP array revealed a 16-cM
(7.3Mb) genomic interval on chromosome 10q26 suggestive for
linkage (LOD score 2.71), containing the STR marker-detected region
as described above. A second, minor linkage peak generating a LOD
score of 1.78 was observed on chromosome 1p13.3 in the region
between 117 and 118 cM (Figure 2). Genotyping and linkage analysis
using highly informative microsatellite markers resulted in negative
LOD scores, thereby excluding 1p13.3 as a potential locus for CORD
in our family. Haplotype analysis combining the data from two
independent genome-wide scans restricted the shared interval to a
6.7-Mb region on chromosome 10q26 between markers D10S1757
(122.32Mb) and D10S1782 (129.08Mb).
Direct exonic sequencing of 46 genes, including splice site junc-
tions, 50 and 30 untranslated regions as well as 4 microRNAs, 5
miscellaneous RNAs, 1 ribosomal RNA, 2 spliceosomal RNAs and 1
small nucleolar RNA, from the critical 6.7-Mb interval was subse-
quently performed, but this led to negative findings in terms of the
underlying molecular pathogenesis of CORD in our pedigree.
Analysis of the entire coding sequences of all positional genes detected
only known polymorphisms. All novel sequence variants were also
observed in one or more individuals in our panel of 192 controls. A
list of the genes and non-coding RNAs mapping to the critical region
on 10q26 is given in Supplementary Table 1.
Initially array CGH (aCGH) technology was used to evaluate the
whole genome followed by the finer analysis of chromosome 10
rearrangements (Supplementary Figure 1). Automated segmentation
Table 1 Two-point LOD scores for linkage between the CORD locus and 10q26 markers
LOD scorea
Two-point Multi-point
Marker Position (Mb)b Y¼0.00 Y¼0.05 Y¼0.10 Y¼0.30 Y¼0.50 Zmax Ymax Y¼0.00
D10S1765 89.60 0.47 0.81 0.90 0.64 0.00 0.90 0.15 4.83
D10S185 95.19 0.80 0.94 0.94 0.45 0.00 0.94 0.10 5.48
D10S1680 95.60 0.80 0.94 0.94 0.45 0.00 0.94 0.10 3.81
D10S1709 99.49 0.80 0.94 0.94 0.45 0.00 0.94 0.10 0.21
D10S192 102.44 2.34 2.13 1.93 0.98 0.00 2.34 0.00 0.81
D10S187 118.65 2.33 2.13 1.93 0.98 0.00 2.33 0.00 0.11
D10S1693 119.44 0.81 0.97 0.98 0.42 0.00 0.98 0.10 2.32
D10S542 120.75 1.19 1.26 1.19 0.50 0.00 1.26 0.05 3.52
D10S1740 121.50 2.15 2.07 1.92 0.98 0.00 2.15 0.00 2.21
D10S1757 122.32 3.31 3.02 2.72 1.31 0.00 3.31 0.00 2.71
D10S1230 122.74 3.31 3.02 2.72 1.31 0.00 3.31 0.00 2.71
D10S1679 123.13 3.31 3.02 2.72 1.31 0.00 3.31 0.00 2.71
D10S1483 123.28 2.33 2.13 1.93 0.98 0.00 2.33 0.00 2.71
D10S587 125.19 3.31 3.02 2.72 1.31 0.00 3.31 0.00 2.71
D10S1213 125.41 3.31 3.02 2.72 1.31 0.00 3.31 0.00 2.71
D10S216 125.59 2.35 2.15 1.94 0.98 0.00 2.35 0.00 2.71
D10S1656 126.00 3.27 2.98 2.68 1.27 0.00 3.27 0.00 2.71
D10S575 127.93 0.64 0.57 0.49 0.17 0.00 0.64 0.00 2.71
D10S214 128.20 2.38 2.18 1.97 0.99 0.00 2.38 0.00 2.71
D10S1703 128.50 0.65 0.57 0.49 0.17 0.00 0.65 0.00 2.71
D10S186 128.79 0.65 0.57 0.49 0.17 0.00 0.65 0.00 2.71
D10S1782 129.50 1.72 1.72 1.61 0.69 0.00 1.72 0.05 infinity
aSignificant LOD scores are shown in bold.
bMb locations based on NCBI map, build 37/hg19.
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analysis for deleted genomic areas predicted multiple segments with
log2 intensity ratios in a wide range, from 0.15 to 0.57 along
chromosome 10, but they were reported as a typical copy number
variation in the human population (Database of Genomic Variants,
http://projects.tcag.ca/variation/). Thus, the aCGH method did not
detect any chromosomal aberration as disease-causing mutation in
the pedigree.
DISCUSSION
In this study, we have described a three-generation Romani family
segregating a novel locus for adCORD. The disease in the pedigree is
best described as cone-rod dystrophy with slightly variable but early
age of onset (around 10 years of age). Ophthalmoscopy disclosed
typical signs of CORD including gradual visual impairment and
photophobia, narrowing of retinal vessels, scattered bone-spicule
pigmentation in the midperipheral retina, RPE (retinal pigment
epithelium) atrophy and optic disk pallor. Electroretinogram showed
reduced photopic and scotopic responses. Visual fields demonstrated
central scotoma.
After the exclusion of known loci associated with adCORD,
pedigree members were first genotyped with short tandem repeat
markers and then with single-nucleotide polymorphism microarray
chip. Advances in SNP identification and genotyping technology have
extended the use of dense SNP maps for linkage purposes in place of
STR marker panels.9 It has been reported that the SNP microarrays
has a greater than 99% chance in detecting heterozygosity, compared
with a 70% chance in the case of STR markers, and consequently in
the generation of better quality linkage data.10 The use of high-density
SNP genotyping platform has successfully identified disease loci in
families with retinitis pigmentosa (RP) and Leber congenital
amaurosis.11,12 For this reason, we undertook a second genome
scan using the 10K SNP array to verify the original STR-based linkage
data for CORD in our pedigree.
Initially, we performed a total-genome search with the use of STR
markers and identified a 6.7-Mb region on chromosome 10q26 for
CORD between markers D10S1757 and D10S1782, with maximum
LOD score of 3.31 in our pedigree. It represents the maximum value
obtainable with this family, given its size, the number of informative
meioses and the described genetic model. An independent genome-
wide scan using SNP microarray defined a 7.3-Mb region on
chromosome 10q26, spanning the 6.7-Mb region highlighted by the
original STR markers, confirming the validity of the initial method.
In addition, the lack of evidence for linkage to other genomic regions
indicates strongly for a novel and only locus for CORD in this region
of the human genome.
According to the human genome build 37 (hg19, 2009), the 10q26
region contains 46 annotated genes. We first sequenced the key
positional candidate genes, including PLEKHA1 (pleckstrin homology
domain-containing family A, member 1; 10q25.3–q26.2), ARMS2
(age-related maculopathy susceptibility, 10q26.13), HTRA1 (HtrA
serine peptidase 1; 10q26.13) and OAT (ornithine aminotransferase;
10q26), as well as RGR (retinal G protein-coupled receptor, 10q23.1)
and OPN4 (opsin 4, 10q23.2) mapping close to the linked interval.
No mutation was found involving the exons, which suggests that
intronic mutation spots acting as cis-regulatory elements, such as
intronic splicing enhancers or silencers, could be involved in the
pathogenesis of adCORD in our family. We then performed exten-
sive screening of all genes (their coding region, splice site junctions,
Figure 2 Genome-wide multipoint LOD score calculations using 10K SNP array genotyping data generated by Genehunter from the easyLINKAGE package.5
Each chromosome on the x-axis is plotted against the LOD score on the y-axis. One clear peak, indicated by arrow, is visible on chromosome 10 with a
genome-wide significant LOD score of 2.71.
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50 and 30 untranslated regions) and 13 non-coding RNAs within the
interval, but it failed to detect any pathogenic variant. However,
mutations in other parts of the genes cannot be excluded. As
previously reported, one of the most frequent causes of Leber
congenital amaurosis (20% of the patients) is a deep intronic
mutation, c.2991þ 1655A4G (p.Cys998X), which results in the
insertion of a cryptic exon in the mRNA and introduces a premature
stop codon in the CEP290 protein.13
High-density oligonucleotide-based aCGH technology was further
applied to search for deletions/insertions as small as a few hundred
base pair that may explain the genetic basis of the disease. No
chromosomal aberration, deletion or amplification of a part or
whole gene was detected in the pedigree, suggesting that a different
mutation-detecting technology such as next-generation sequencing
may need to be used.
In conclusion, here we report the mapping of a novel adCORD
locus to the long arm of chromosome 10 in a Romani family. This is
the first study of the molecular basis of CORD and only the second
study of retinal degenerations in Romani families. Previously muta-
tions in PRPF31 and RPGR have been found to be causative for adRP
and XlRP, respectively, in two Bulgarian Romani families.14
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